Skip to main content
NCBI home page
Gut logoLink to Gut
. 1994 Nov;35(11):1608–1612. doi: 10.1136/gut.35.11.1608

Clinical significance of Clostridium difficile and its toxins in faeces of immunocompromised children.

M J Wolfhagen 1, K Meijer 1, A C Fluit 1, R Torensma 1, R A Bruinsma 1, A Fleer 1, J Verhoef 1
PMCID: PMC1375621  PMID: 7828982

Abstract

In this study, clinical and laboratory findings were tested for correlation with the presence of Clostridium difficile. The toxigenicity of the isolated strains and the toxins were determined in faecal samples of immunocompromised children admitted to a single room for protective isolation. Using the toxin assay as the gold standard, the culture sensitivity of toxigenic C difficile was 94.1%, the specificity 93.8%, the positive predictive value 62.8%, and the negative predictive value 99.3%. Correction for stools with a positive culture of toxigenic C difficile preceding detection of toxin, resulted in a positive prediction value of 78.4%. A statistically significant association was found between a positive faecal toxin assay and fever, and between a positive culture of toxigenic C difficile and abdominal pain: 42% of the patients with positive toxin assays had fever versus 21% with negative toxin assays, and 66% of the patients with a positive culture for toxigenic C difficile had abdominal pain, versus 22% with negative cultures. Further analysis of the cultures and toxin assays showed no statistically significant association with diarrhoea, fever, white blood cell count, C reactive protein concentrations, or abdominal pain. Based on these findings, it is suggested that immunocompromised children should be treated when toxigenic C difficile is cultured or when toxin is detected in stool samples.

Full text

PDF
1608

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler S. P., Chandrika T., Berman W. F. Clostridium difficile associated with pseudomembranous colitis. Occurrence in a 12-week-old infant without prior antibiotic therapy. Am J Dis Child. 1981 Sep;135(9):820–822. [PubMed] [Google Scholar]
  2. Barroso L. A., Wang S. Z., Phelps C. J., Johnson J. L., Wilkins T. D. Nucleotide sequence of Clostridium difficile toxin B gene. Nucleic Acids Res. 1990 Jul 11;18(13):4004–4004. doi: 10.1093/nar/18.13.4004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bartlett J. G. Antibiotic-associated diarrhea. Clin Infect Dis. 1992 Oct;15(4):573–581. doi: 10.1093/clind/15.4.573. [DOI] [PubMed] [Google Scholar]
  4. Bolton R. P., Tait S. K., Dear P. R., Losowsky M. S. Asymptomatic neonatal colonisation by Clostridium difficile. Arch Dis Child. 1984 May;59(5):466–472. doi: 10.1136/adc.59.5.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brettle R. P., Wallace E. Clostridium difficile from stools of normal children. Lancet. 1982 May 22;1(8282):1193–1193. doi: 10.1016/s0140-6736(82)92266-8. [DOI] [PubMed] [Google Scholar]
  6. Chang T. W., Sullivan N. M., Wilkins T. D. Insusceptibility of fetal intestinal mucosa and fetal cells to Clostridium difficile toxins. Zhongguo Yao Li Xue Bao. 1986 Sep;7(5):448–453. [PubMed] [Google Scholar]
  7. Cudmore M. A., Silva J., Jr, Fekety R., Liepman M. K., Kim K. H. Clostridium difficile colitis associated with cancer chemotherapy. Arch Intern Med. 1982 Feb;142(2):333–335. [PubMed] [Google Scholar]
  8. Donta S. T., Myers M. G. Clostridium difficile toxin in asymptomatic neonates. J Pediatr. 1982 Mar;100(3):431–434. doi: 10.1016/s0022-3476(82)80454-x. [DOI] [PubMed] [Google Scholar]
  9. George W. L., Rolfe R. D., Finegold S. M. Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions. J Clin Microbiol. 1982 Jun;15(6):1049–1053. doi: 10.1128/jcm.15.6.1049-1053.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gerding D. N., Olson M. M., Peterson L. R., Teasley D. G., Gebhard R. L., Schwartz M. L., Lee J. T., Jr Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. Arch Intern Med. 1986 Jan;146(1):95–100. [PubMed] [Google Scholar]
  11. Gryboski J. D., Pellerano R., Young N., Edberg S. Positive role of Clostridium difficile infection in diarrhea in infants and children. Am J Gastroenterol. 1991 Jun;86(6):685–689. [PubMed] [Google Scholar]
  12. Hyams J. S., Berman M. M., Helgason H. Nonantibiotic-associated enterocolitis caused by Clostridium difficile in an infant. J Pediatr. 1981 Nov;99(5):750–752. doi: 10.1016/s0022-3476(81)80402-7. [DOI] [PubMed] [Google Scholar]
  13. Kamthan A. G., Bruckner H. W., Hirschman S. Z., Agus S. G. Clostridium difficile diarrhea induced by cancer chemotherapy. Arch Intern Med. 1992 Aug;152(8):1715–1717. [PubMed] [Google Scholar]
  14. Kato N., Ou C. Y., Kato H., Bartley S. L., Brown V. K., Dowell V. R., Jr, Ueno K. Identification of toxigenic Clostridium difficile by the polymerase chain reaction. J Clin Microbiol. 1991 Jan;29(1):33–37. doi: 10.1128/jcm.29.1.33-37.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kim K., DuPont H. L., Pickering L. K. Outbreaks of diarrhea associated with Clostridium difficile and its toxin in day-care centers: evidence of person-to-person spread. J Pediatr. 1983 Mar;102(3):376–382. doi: 10.1016/s0022-3476(83)80652-0. [DOI] [PubMed] [Google Scholar]
  16. Kim K., Pickering L. K., DuPont H. L., Sullivan N., Wilkins T. In vitro and in vivo neutralizing activity of human colostrum and milk against purified toxins A and B of Clostridium difficile. J Infect Dis. 1984 Jul;150(1):57–62. doi: 10.1093/infdis/150.1.57. [DOI] [PubMed] [Google Scholar]
  17. Larson H. E., Barclay F. E., Honour P., Hill I. D. Epidemiology of Clostridium difficile in infants. J Infect Dis. 1982 Dec;146(6):727–733. doi: 10.1093/infdis/146.6.727. [DOI] [PubMed] [Google Scholar]
  18. Levett P. N. Effect of antibiotic concentration in a selective medium on the isolation of Clostridium difficile from faecal specimens. J Clin Pathol. 1985 Feb;38(2):233–234. doi: 10.1136/jcp.38.2.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lyerly D. M., Krivan H. C., Wilkins T. D. Clostridium difficile: its disease and toxins. Clin Microbiol Rev. 1988 Jan;1(1):1–18. doi: 10.1128/cmr.1.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mevissen-Verhage E. A., Marcelis J. H., de Vos M. N., Harmsen-van Amerongen W. C., Verhoef J. Bifidobacterium, Bacteroides, and Clostridium spp. in fecal samples from breast-fed and bottle-fed infants with and without iron supplement. J Clin Microbiol. 1987 Feb;25(2):285–289. doi: 10.1128/jcm.25.2.285-289.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Mårdh P. A., Helin I., Colleen I., Oberg M., Holst E. Clostridium difficile toxin in faecal specimens of healthy children and children with diarrhoea. Acta Paediatr Scand. 1982 Mar;71(2):275–278. doi: 10.1111/j.1651-2227.1982.tb09414.x. [DOI] [PubMed] [Google Scholar]
  22. Nash J. Q., Chattopadhyay B., Honeycombe J., Tabaqchali S. Clostridium difficile and cytotoxin in routine faecal specimens. J Clin Pathol. 1982 May;35(5):561–565. doi: 10.1136/jcp.35.5.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Nielsen H., Daugaard G., Tvede M., Bruun B. High prevalence of Clostridium difficile diarrhoea during intensive chemotherapy for disseminated germ cell cancer. Br J Cancer. 1992 Oct;66(4):666–667. doi: 10.1038/bjc.1992.334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pruksananonda P., Powell K. R. Multiple relapses of Clostridium difficile-associated diarrhea responding to an extended course of cholestyramine. Pediatr Infect Dis J. 1989 Mar;8(3):175–178. [PubMed] [Google Scholar]
  25. Shuttleworth R., Taylor M., Jones D. M. Antimicrobial susceptibilities of Clostridium difficile. J Clin Pathol. 1980 Oct;33(10):1002–1005. doi: 10.1136/jcp.33.10.1002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sutphen J. L., Grand R. J., Flores A., Chang T. W., Bartlett J. G. Chronic diarrhea associated with Clostridium difficile in children. Am J Dis Child. 1983 Mar;137(3):275–278. doi: 10.1001/archpedi.1983.02140290061016. [DOI] [PubMed] [Google Scholar]
  27. Tullus K., Aronsson B., Marcus S., Möllby R. Intestinal colonization with Clostridium difficile in infants up to 18 months of age. Eur J Clin Microbiol Infect Dis. 1989 May;8(5):390–393. doi: 10.1007/BF01964052. [DOI] [PubMed] [Google Scholar]
  28. Tvede M., Schiøtz P. O., Krasilnikoff P. A. Incidence of Clostridium difficile in hospitalized children. A prospective study. Acta Paediatr Scand. 1990 Mar;79(3):292–299. doi: 10.1111/j.1651-2227.1990.tb11459.x. [DOI] [PubMed] [Google Scholar]
  29. Wolfhagen M. J., Fluit A. C., Jansze M., Rademaker C. M., Verhoef J. Detection of toxigenic Clostridium difficile in fecal samples by colony blot hybridization. Eur J Clin Microbiol Infect Dis. 1993 Jun;12(6):463–466. doi: 10.1007/BF01967444. [DOI] [PubMed] [Google Scholar]
  30. Wolfhagen M. J., Fluit A. C., Torensma R., Jansze M., Kuypers A. F., Verhage E. A., Verhoef J. Comparison of typing methods for Clostridium difficile isolates. J Clin Microbiol. 1993 Aug;31(8):2208–2211. doi: 10.1128/jcm.31.8.2208-2211.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES